These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33575313)

  • 21. Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.
    Aggarwal AN; Prasad KT; Muthu V
    Curr Opin Pulm Med; 2022 Mar; 28(2):84-92. PubMed ID: 34652297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 Pandemic.
    Chan KF; Kwok WC; Ma TF; Hui CH; Tam TC; Wang JK; Ho JC; Lam DC; Sau-Man Ip M; Ho PL
    Ann Am Thorac Soc; 2021 Oct; 18(10):1624-1633. PubMed ID: 33636091
    [No Abstract]   [Full Text] [Related]  

  • 23. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.
    Calmes D; Graff S; Maes N; Frix AN; Thys M; Bonhomme O; Berg J; Debruche M; Gester F; Henket M; Paulus V; Duysinx B; Heinen V; Dang DN; Paulus A; Quaedvlieg V; Vaillant F; Van Cauwenberge H; Malaise M; Gilbert A; Ghuysen A; Gillet P; Moutschen M; Misset B; Sibille A; Guiot J; Corhay JL; Louis R; Schleich F
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):160-169. PubMed ID: 33038592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid decline of seasonal influenza during the outbreak of COVID-19.
    Young G; Peng X; Rebeza A; Bermejo S; De C; Sharma L; Dela Cruz CS
    ERJ Open Res; 2020 Jul; 6(3):. PubMed ID: 32832527
    [No Abstract]   [Full Text] [Related]  

  • 25. The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids.
    Gonzalez-Barcala FJ; Nieto-Fontarigo JJ; Mendez-Brea P; Salgado FJ
    ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35651364
    [No Abstract]   [Full Text] [Related]  

  • 26. Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency.
    Kappe NN; Alagem N; Tov N; Stolk J
    COPD; 2023 Dec; 20(1):292-297. PubMed ID: 37665565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales.
    Alsallakh MA; Sivakumaran S; Kennedy S; Vasileiou E; Lyons RA; Robertson C; Sheikh A; Davies GA;
    BMC Med; 2021 May; 19(1):124. PubMed ID: 33993870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the COVID-19 pandemic on COPD exacerbations in Japanese patients: a retrospective study.
    Nishioki T; Sato T; Okajima A; Motomura H; Takeshige T; Watanabe J; Yae T; Koyama R; Kido K; Takahashi K
    Sci Rep; 2024 Feb; 14(1):2792. PubMed ID: 38307984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is asthma a risk factor for COVID-19? Are phenotypes important?
    Muñoz X; Pilia F; Ojanguren I; Romero-Mesones C; Cruz MJ
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33527078
    [No Abstract]   [Full Text] [Related]  

  • 30. Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders.
    Weiden MD; Zeig-Owens R; Singh A; Schwartz T; Liu Y; Vaeth B; Nolan A; Cleven KL; Hurwitz K; Beecher S; Prezant DJ
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33527077
    [No Abstract]   [Full Text] [Related]  

  • 31. In the eye of the storm: impact of COVID-19 pandemic on admission patterns to paediatric intensive care units in the UK and Eire.
    Kanthimathinathan HK; Buckley H; Davis PJ; Feltbower RG; Lamming C; Norman L; Palmer L; Peters MJ; Plunkett A; Ramnarayan P; Scholefield BR; Draper ES
    Crit Care; 2021 Nov; 25(1):399. PubMed ID: 34789305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of COVID-19 on Hospital Admissions for COPD Exacerbation: Lessons for Future Care.
    Lawless M; Burgess M; Bourke S
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056374
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease in Exacerbations During the Coronavirus Disease 2019 Pandemic in a Cohort of Veterans with COPD.
    Trujillo C; Garnet B; Zadeh AV; Urdaneta G; Campos M
    Chronic Obstr Pulm Dis; 2021 Oct; 8(4):572-579. PubMed ID: 34592084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and Outcomes of Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Australia and New Zealand.
    Berenyi F; Steinfort DP; Abdelhamid YA; Bailey MJ; Pilcher DV; Bellomo R; Finnis ME; Young PJ; Deane AM
    Ann Am Thorac Soc; 2020 Jun; 17(6):736-745. PubMed ID: 32135066
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of the COVID-19 pandemic on acute otolaryngology inpatient activity at a tertiary referral centre: A retrospective analysis.
    Deekonda P; Mirza AH; Jones H
    Clin Otolaryngol; 2022 May; 47(3):447-454. PubMed ID: 35191188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asthma admission among children in Hong Kong during the first year of the COVID-19 pandemic.
    Wong KL; Wong WHS; Yau YS; Lee SL; Chiu SSS
    Pediatr Pulmonol; 2022 Dec; 57(12):3104-3110. PubMed ID: 36097891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK.
    Yakutcan U; Hurst JR; Lebcir R; Demir E
    BMJ Open; 2022 Oct; 12(10):e062305. PubMed ID: 36207043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing traditional bibliometrics and Altmetric assessments of research impact in respiratory disease.
    Dutt E; Hurst JR
    ERJ Open Res; 2023 Nov; 9(6):. PubMed ID: 38020558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.